Kedrion | Finanzwire

Basculer en Français

10279	Companies
212816	Keywords
142597	Articles
112686	Press releases

Home
Companies
Kedrion

BRIEF

published on 11/27/2025 at 10:10, 4 months 27 days ago

EMA Grants Orphan Drug Designation to Kedrion's Treatment for ACP

Biopharmaceutical Innovation Kedrion Orphan Drug EMA Approval Iron Metabolism
PRESS RELEASE

published on 11/27/2025 at 10:05, 4 months 27 days ago

European Medicines Agency (EMA) grants Orphan Drug Designation to Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia, a rare genetic disorder of iron metabolism
Kedrion's plasma-derived treatment for Congenital Aceruloplasminemia granted Orphan Drug Designation by EMA, highlighting commitment to rare disease innovation

Orphan Drug Designation Rare Disease Kedrion Plasma-derived Treatment Congenital Aceruloplasminemia
BRIEF

published on 11/06/2025 at 14:50, 5 months 18 days ago

Kedrion Highlights Secondary Immunodeficiencies at IPIC 2025

Kedrion Biopharma Hematologic Malignancies Secondary Immunodeficiencies IPIC 2025 Immunoglobulin Therapy
PRESS RELEASE

published on 11/06/2025 at 14:45, 5 months 18 days ago

Secondary Immunodeficiencies in the spotlight at IPIC 2025: Kedrion champions innovation and patient care
Kedrion Biopharma shines spotlight on Secondary Immunodeficiencies at IPIC 2025, highlighting challenges and advances in patient care

Innovation Patient Care Kedrion Biopharma Secondary Immunodeficiencies IPIC 2025

Accesswire

Published on 04/24/2026 at 15:00, 2 hours 47 minutes ago

Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 15:00, 2 hours 47 minutes ago

First Canadian Graphite Appoints Scott Kelly As Chief Financial Officer
Published on 04/24/2026 at 14:30, 3 hours 17 minutes ago

Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)
Published on 04/24/2026 at 14:00, 3 hours 47 minutes ago

Datametrex Expands Patent Monetization Strategy Adding Quantum-Resilient Encryption Technologies
Published on 04/24/2026 at 13:30, 4 hours 17 minutes ago

Alset AI Announces Closing of Second Tranche of Loan Transaction of up to $3 Million

View all ACCESSWIRE

EQS Group

Published on 04/24/2026 at 17:21, 26 minutes ago

Grand City Properties S.A. announces successful issuance of €600 million perpetual notes and launch of tender offer
Published on 04/24/2026 at 17:18, 28 minutes ago

Grand City Properties S.A. announces successful issuance of €600 million perpetual notes and launch of tender offer
Published on 04/24/2026 at 17:08, 38 minutes ago

Berliner Effektengesellschaft AG publishes its 2025 separate and consolidated financail statements
Published on 04/24/2026 at 17:00, 47 minutes ago

Sunshare Unveils Next-Generation Balcony Solar Systems at Solar Solutions Wien 2026
Published on 04/24/2026 at 17:00, 47 minutes ago

Delivery Hero Unveils Herogen – Autonomous AI Agent Unlocks 130-Person Engineering Output

Les Echos

Published on 04/24/2026 at 16:37, 1 hour 9 minutes ago

Availability of the 2025 Universal Registration Document (URD)
Published on 04/23/2026 at 19:27, 22 hours 20 minutes ago

Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 23 hours 29 minutes ago

Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
Published on 04/23/2026 at 18:00, 23 hours 47 minutes ago

First-quarter 2026 Sales
Published on 04/23/2026 at 18:00, 23 hours 47 minutes ago

2025 Full-Year Results: Strong Top-Line Rebound (+26%)

View all LES ECHOS COMFI WIRE